IDEXX LABORATORIES INC /DE·4

May 14, 5:00 PM ET

Kingsley Lawrence D 4

4 · IDEXX LABORATORIES INC /DE · Filed May 14, 2026

Research Summary

AI-generated summary of this filing

Updated

IDEXX (IDXX) Lead Director Lawrence D. Kingsley Receives Awards

What Happened

  • Lawrence D. Kingsley, a director and the company’s Lead Director, received awards from IDEXX on 2026-05-12 totaling 1,002 share-equivalents (derivative grants). The grants were recorded at $0.00 (standard for awards/RSUs and option grants) and consist of stock option grants and restricted stock units (RSUs). These are awards (insider transaction code A), not open-market purchases or sales.

Key Details

  • Transaction date: 2026-05-12; Form 4 filed 2026-05-14 (filed timely within the usual 2-business-day window).
  • Grants: 525 + 168 + 234 + 75 = 1,002 share-equivalents (all reported as acquisitions at $0.00).
  • Vesting/terms: Footnotes state option grants vest in one installment on the one-year anniversary of the grant or on the date of the 2027 annual shareholders’ meeting, whichever is earlier (F1). An additional grant was made in connection with the Lead Director role (F2). Each RSU equals a contingent right to one share and vests on the same schedule (F3).
  • Shares owned after transaction: Not provided in the excerpt of the filing.
  • Filing timeliness: Not late; filed within the standard reporting period.

Context

  • These are standard director compensation awards. Options give the right to buy shares at a set price (exercise price not shown here) once vested; RSUs convert to actual shares on vesting. Because these are grants rather than purchases or sales, they reflect compensation rather than an immediate personal investment or divestment by the director.

Insider Transaction Report

Form 4
Period: 2026-05-12
Transactions
  • Award

    Non-Qualified Stock Option (right-to-buy)

    [F1]
    2026-05-12+525525 total
    Exercise: $533.92Exp: 2036-05-11Common Stock (525 underlying)
  • Award

    Non-Qualified Stock Option (right-to-buy)

    [F2][F1]
    2026-05-12+168168 total
    Exercise: $533.92Exp: 2036-05-11Common Stock (168 underlying)
  • Award

    Restricted Stock Unit

    [F3]
    2026-05-12+234234 total
    Common Stock (234 underlying)
  • Award

    Restricted Stock Unit

    [F3][F2]
    2026-05-12+7575 total
    Common Stock (75 underlying)
Footnotes (3)
  • [F1]Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier.
  • [F2]Additional grant as Lead Director.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier.
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Lawrence D. Kingsley|2026-05-14

Documents

1 file
  • 4
    wk-form4_1778792440.xmlPrimary

    FORM 4